Suryoday Cancer And Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 1 Year 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.50 Cr
as on 13-12-2024
About Suryoday Cancer And Research
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.50 Cr.
Satish Sonawane, Bhushan Nikam, and Sonal Nikam serve as directors at the Company.
- CIN/LLPIN
U86100MH2023PTC400578
- Company No.
400578
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2023
- Date of AGM
06 Dec 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Suryoday Cancer And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Sonawane  | Director | 11-Apr-2023 | Current |
| Bhushan Nikam | Director | 11-Apr-2023 | Current |
| Sonal Nikam | Director | 11-Apr-2023 | Current |
Financial Performance of Suryoday Cancer And Research.
Enhance accessibility to Suryoday Cancer And Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Suryoday Cancer And Research?
Unlock access to Suryoday Cancer And Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Varad Multispeciality Hospital Private LimitedActive 10 years 11 monthsSatish Sonawane is a mutual person
- Sai Cancer And Research Services Private LimitedActive 9 years 7 months
Satish Sonawane and Bhushan Nikam are mutual person
- Sai Nuclear Private LimitedActive 2 years 7 months
Satish Sonawane, Bhushan Nikam and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Apr 2024 | ₹6.50 Cr | Open |
How Many Employees Work at Suryoday Cancer And Research?
Unlock and access historical data on people associated with Suryoday Cancer And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suryoday Cancer And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suryoday Cancer And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.